Molecular Modeling Approaches in the Discovery of New Drugs for Anti-Cancer Therapy: The Investigation of p53-MDM2 Interaction and its Inhibition by Small Molecules

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|17|28|3142-3154

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.28, 2010-09, pp. : 3142-3154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?

By  

Current Medicinal Chemistry, Vol. 21, Iss. 5, 2014-02 ,pp. : 553-574

Bentham Science Publishers

Access to resources Recommend Favorite

p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents

By  

Current Cancer Drug Targets, Vol. 18, Iss. 8, 2018-10 ,pp. : 749-772

Bentham Science Publishers

Access to resources Recommend Favorite

The p53-Mdm2 Pathway: Targets for the Development of New Anticancer Therapeutics

By  

Mini Reviews in Medicinal Chemistry, Vol. 3, Iss. 3, 2003-05 ,pp. : 257-270

Bentham Science Publishers

Access to resources Recommend Favorite

Patented small molecule inhibitors of p53–MDM2 interaction

By Deng Jinxia   Dayam Raveendra   Neamati Nouri  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 2, 2006-02 ,pp. : 165-188

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Inhibitors of p53/MDM2 Interaction

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 2, 2005-04 ,pp. : 159-165

Bentham Science Publishers

Access to resources Recommend Favorite